ImageneBio IMA Income Statement (2020-2025)

NASDAQ IMA
$5.61 +0.10 (+1.81%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
3.47M3.55M3.75M20.22M3.38M0.38M6.40M5.45M5.31M2.00M1.19M0.66M3.50M0.80M
Operating items
Research & Development (Quarter)
10.02M11.37M13.38M12.34M14.34M15.49M18.85M15.64M15.55M15.17M14.65M14.27M14.00M9.83M3.88M2.52M4.04M4.03M15.56M
Selling, General & Administrative (Quarter)
3.17M4.86M4.89M5.09M6.00M5.84M5.43M4.92M5.28M5.32M6.03M8.29M6.00M5.31M1.65M17.67M2.75M4.42M11.04M
Restructuring Costs (Quarter)
2.60M0.68M0.41M-0.54M1.44M0.31M2.85M
Other Operating Expenses (Quarter)
-4.37M-0.41M4.96M-1.44M-2.85M
Operating Expenses (Quarter)
13.19M16.24M18.27M17.43M20.35M21.33M24.28M20.56M20.83M20.49M20.69M22.57M18.23M15.82M5.54M24.61M6.79M8.75M26.59M
Operating Income (Quarter)
-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M-6.00M-8.75M-26.59M
EBIT (Quarter)
-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M-6.00M-8.75M-26.59M
Non-operating items
Interest & Investment Income (Quarter)
0.01M0.01M0.01M0.17M0.46M0.55M1.01M1.30M1.38M2.16M2.27M2.11M1.92M1.77M1.57M1.42M1.29M
Other Non Operating Income (Quarter)
0.00M0.01M0.01M0.01M-0.05M0.46M0.54M1.02M0.57M-0.01M-0.00M-0.01M-0.01M0.23M-1.19M3.76M-0.01M4.71M1.84M
Non Operating Income (Quarter)
0.12M0.46M0.54M1.30M1.38M2.16M2.26M2.11M2.15M-1.15M10.79M-0.08M6.00M1.74M
Net income details
EBT (Quarter)
-121.50M-54.15M-49.38M-30.48M-22.57M-2143.94M-1050.19M-15.86M-14.22M-17.11M-17.34M-19.65M-16.12M-13.67M-3.18M-17.33M-6.08M-2.75M-24.85M
Tax Provisions (Quarter)
0.03M0.06M0.15M0.03M0.01M-0.10M
Profit After Tax (Quarter)
-9.72M-12.68M-14.52M2.80M-16.84M-20.49M-17.34M-14.86M-14.22M-17.11M-17.34M-19.49M-22.31M-6.26M-6.18M-8.72M-9.13M-7.58M-25.62M
Income from Continuing Operations (Quarter)
-121.50M-54.15M-49.38M-30.48M-22.57M-2143.94M-1050.19M-15.86M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-2.77M-24.75M
Consolidated Net Income (Quarter)
-121.50M-54.15M-49.38M-30.48M-22.57M-2143.94M-1050.19M-15.86M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-2.77M-24.75M
Income towards Parent Company (Quarter)
-121.50M-54.15M-49.38M-30.48M-22.57M-2143.94M-1050.19M-15.86M-14.22M-17.11M-17.34M-19.65M-16.15M-13.73M-3.18M-17.48M-6.11M-2.77M-24.75M
Preferred Dividend Payments (Quarter)
2.85M2.91M3.00M3.05M3.15M0.85M
Net Income towards Common Stockholders (Quarter)
-121.50M-54.15M-49.38M-30.48M-22.57M-2143.94M-1050.19M-15.86M-14.22M-17.11M-17.34M-19.65M-19.00M-16.64M-6.18M-17.48M-9.13M-5.92M-25.62M
Additional items
EPS (Basic) (Quarter)
-378.69-18.12-16.53-13.07-7.51-711.49-347.59-5.26-4.71-5.23-4.79-5.65-4.72-4.14-1.54-4.35-2.27-1.47-3.01
EPS (Diluted) (Quarter)
-18.12-16.53-13.07-7.51-711.49-347.59-5.26-4.71-5.23-4.79-5.65-4.72-4.14-1.54-4.35-2.27-1.47-3.01
Shares Outstanding (Quarter)
0.32M2.99M2.99M2.33M3.01M3.01M3.02M3.02M3.02M3.27M3.62M3.48M4.02M4.02M4.02M4.02M4.02M4.02M8.53M8.53M
Shares Outstanding (Diluted) (Quarter)
2.99M2.99M2.33M3.01M3.01M3.02M3.02M3.02M3.27M3.62M3.48M4.02M4.02M4.02M4.02M4.02M4.02M8.53M8.53M
Shares Outstanding (Entity) (Quarter)
0.32M2.99M2.99M2.33M3.01M3.02M3.02M3.02M3.02M3.52M3.68M4.02M4.02M4.02M4.02M4.02M4.02M4.02M8.53M11.18M
EBITDA (Quarter)
-9.72M-12.69M-14.52M2.79M-16.96M-20.95M-17.88M-15.11M-15.52M-18.49M-19.50M-21.91M-18.23M-15.82M-2.04M-28.11M-6.00M-8.75M-26.59M
Interest Expenses (Quarter)
111.78M41.47M34.87M33.27M5.78M2,123.45M1,032.86M1.76M2.04M12.17M4.06M2.53M0.31M0.48M0.63M4.08M0.01M0.02M2.90M0.00M
Tax Rate (Quarter)
-0.17%-0.45%-0.88%-0.46%-0.55%0.40%